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OBJECTIVE The purpose of this study is to review the clinical course of persistent junctional reciprocating
tachycardia (PJRT) in 21 patients spanning a wide age range to examine the electrophysi-
ologic characteristics of the conduction system in these patients with PJRT, particularly in
regards to its incessant nature and to evaluate the long-term response to radiofrequency
ablation.
BACKGROUND Persistent junctional reciprocating tachycardia is uncommon, occurring in 1% of patients with
supraventricular tachycardia. Its presentation, course and treatment are incompletely charac-
terized.
METHODS The clinical, electrocardiographic, electrophysiologic and echocardiographic data of 21
patients with PJRT were reviewed.
RESULTS In 9 of these 21 patients, the mean tachycardia cycle length increased significantly (p ,
0.0001) as the patients grew, from a mean tachycardia cycle length of 308 6 64 ms in the
patients less than 2 years, 414 6 57 ms in the patients between 2 years and 5 years, to 445 6
57 ms in the patients greater than 5 years, primarily due to slowing of retrograde conduction
in the accessory pathway. Persistent junctional reciprocating tachycardia was associated with
impaired ventricular function in 11, improving spontaneously in 4 and, after successful
ablation of the accessory pathway, in 7. All patients except one were uncontrolled on one or
more medications. Ablation of the accessory pathway was successful in 19 of 21 patients.
CONCLUSIONS We conclude that PJRT is characterized by an onset in early childhood and by an age-related
prolongation of the tachycardia cycle length mediated primarily through conduction delay in
the concealed, retrogradely conducting accessory pathway. Ablation of the accessory pathway
provides definitive treatment for PJRT. (J Am Coll Cardiol 1999;33:366–75) © 1999 by the
American College of Cardiology
Persistent or permanent junctional reciprocating tachycardia
(PJRT), originally described by Coumel et al. in 1967 (1) is
an infrequent form of reentrant supraventricular tachycardia
(1% of patients presenting with supraventricular tachycardia
to the Pediatric Arrhythmia Clinic at the University of
Michigan). Tachycardia is virtually incessant, at a rate
ranging from 120 to 250 beats/minute. The electrocardio-
gram inscribes inverted P waves in leads II, III, AVF, as well
as left lateral leads, along with a P-R interval shorter than
the R-P interval during the tachycardia. The characteristic,
but not diagnostic, electrocardiographic feature is a long
R-P interval consistent with slow retrograde conduction
(Fig. 1) (2–6). During the tachycardia, the cardiac impulse
conducts anterogradely through the atrioventricular node
and His-Purkinje system, returning retrogradely through
the slowly conducting accessory pathway that is usually, but
not always, near the ostium of the coronary sinus (7). Since
the advent of radiofrequency ablation (RFA), several reports
have emphasized the usefulness of radiofrequency ablation
or surgery for the treatment of PJRT (7–10). The purpose of
this study is threefold: first, to review the clinical course of
PJRT in a group of 21 patients across a wide age range
collected from two centers; second, to examine the electro-
physiologic characteristics of the conduction system in
patients with PJRT, particularly in regards to its incessant
nature; and, third, to evaluate the long-term response to
radiofrequency ablation.
METHODS
The clinical, electrocardiographic, electrophysiologic, and
echocardiographic data of 21 patients with PJRT seen at 2
institutions between 1989 and 1995 were reviewed. Elec-
trophysiologic criteria for the diagnosis of PJRT include the
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presence of a long R-P interval, narrow complex tachycar-
dia, transient interruption of PJRT by programmed stimu-
lation with resumption of tachycardia after one or a few
sinus beats, either advancement or delay (or termination of
PJRT without an atrial capture) of the atrial electrogram
with identical atrial activation sequence during PJRT by a
ventricular extrastimulus when the His bundle is refractory,
atrial activation sequence during ventricular pacing identical
to the pattern during tachycardia and, finally, no antero-
grade conduction (unidirectional block) through the acces-
sory pathway, but intact, slow, decremental retrograde
conduction through the accessory pathway (11).
Electrocardiograms (ECG) were reviewed and the R-R,
P-R (defined as the onset of the P wave to the Q or R wave
in the QRS complex), and R-P intervals (calculated as the
difference between the R-R interval and the R-P interval)
were measured. Serial ECG’s were available from 9 patients
presenting within the first 2 years of life. The intervals from
these serial ECG’s were then plotted as a function of the
patient’s age. Serial echocardiograms were reviewed and the
patients’ shortening fraction, ejection fraction, E-point
sepal separation and associated valvar regurgitation were
measured. Decreased ventricular function was defined by a
shortening fraction of less than 0.30 and/or left ventricular
ejection fraction of less than 0.50 and presence of E-point
septal separation.
Informed consent for electrophysiologic (EP) study (n 5
21) and radiofrequency ablation (n 5 20) was obtained from
all patients/parents who underwent electrophysiologic study
(median age of 12.8 years; mean 17.1 years, range 3.7 to
83.6 years). The indications for EP study included deter-
mination of the mechanism of the arrhythmia (n 5 21),
drug testing (n 5 3) and impaired ventricular function (n 5
6, transient in 4 of these). With the advent of transcatheter
treatment of arrhythmias, persistent tachycardia in all (ex-
cept #14 when on amiodarone therapy) led to the recom-
mendation of radiofrequency ablation. Medications were
discontinued at least 5 half-lives prior to electrophysiologic
study except in the one patient taking amiodarone (#14).
Electrophysiologic study was performed as previously de-
scribed (11,12). The retrograde effective and functional
refractory periods were measured using extrastimulation
coupled to either the ventricular depolarization during the
tachycardia or the drive cycle length during ventricular
pacing. In addition the ventricular pacing rate at which
retrograde block occurred during rapid ventricular pacing
was determined. Retrograde properties of the accessory
pathway were distinguished from those of the His-Purkinje
atrioventricular node system by recording and measuring at
the mapped site of the pathway distant from the recordings
in the His bundle region.
One 15-year-old boy was treated by intraoperative cryo-
ablation prior to the advent of radiofrequency ablation.
Radiofrequency energy was delivered to ablate the accessory
pathway supporting the tachycardia in the other 20 patients.
Figures 1–3 suggested that the electrocardiographic in-
tervals increased with age. Therefore, the electrocardio-
graphic intervals (R-R, P-R, R-P in msec) from the 9
patients who presented before age 2 years were classified by
patient age into 3 groups (#2 years, .2 # 5 years, and .5
years). The grouped data were then expressed as the mean
and 1 standard deviation and compared by an analysis of
Abbreviations and Acronyms
ERP 5 effective refractory period
FRP 5 functional refractory period
PJRT 5 persistent junctional reciprocating tachycardia
RFA 5 radiofrequency ablation
V-A 5 ventriculo-atrial
Figure 1. Twelve lead electrocardiogram demonstrating typical PJRT in a 12 year old girl. Note the negative P waves in leads II, III, AVF,
and the lateral precordial leads. The P-R interval is shorter than the R-P interval.
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variance with Bonferroni correction (Statview v4.57 Abacus
Concepts, Inc. 1992–1996). To examine for possible differ-
ences in retrograde and antegrade conduction times among
the 7 patients in whom data were available, the means and
the standard deviations of these 2 parameters were com-
puted and compared by an analysis of variance (Statview
v4.57 Abacus Concepts, Inc. 1992–1996). Finally, to exam-
ine for possible differences in retrograde conduction be-
tween our patients with either incessant tachycardia (n 5
19) and paroxysmal tachycardia (n 5 3), the mean cycle
length and retrograde conduction intervals along with their
standard deviations were computed and compared by a
nonparametric t-test (Microsoft Excel v7.0a, Microsoft
Corp. 1995). A p value #0.05 was taken to denote statistical
significance.
RESULTS
Clinical course. The demographic and electrocardio-
graphic data are summarized in Table 1. Twenty-one
patients at two centers met electrocardiographic and elec-
trophysiologic criteria for PJRT. There was an equal distri-
bution between male and female. Ten patients presented at
birth and one at 6 months of age, all with incessant
tachycardia. By 5 years of age, (during Holter examination
on no medication) one patient (#11) demonstrated only rare
beats and brief nonsustained runs of PJRT; during isopro-
terenol infusion at electrophysiologic study at age 12 years,
his tachycardia became constant. The remaining 10 patients
presented from 4.4 years to 83 years of age; prior duration of
PJRT was unknown. Two of these patients (#10 and #18)
demonstrated persistent tachycardia when first seen 1 (#10)
to 10 (#18) years prior to ablation; #18 had received
antiarrhythmic medication intermittently without discern-
ible effect. Both patients required isoproterenol infusion
during the electrophysiologic study to render the tachycar-
dia persistent. The 4 oldest patients presented with de-
creased exercise tolerance or syncope. All patients, except
for 2, had been treated with more than one medication to
control the tachycardia (Table 2). The tachycardia persisted
despite multiple antiarrhythmic medications except one
who was treated with amiodarone (#14). Tachycardia was
eliminated in 19 of 21 patients (radiofrequency ablation in
18 and cryoablation at surgery in 1). Ventricular function
improved in all patients who had prior evidence of decreased
function. Follow up ranged from 2.9 to 8 years; all 21
patients are alive, including the 2 with unsuccessful ablation
of the pathway.
Electrocardiogram. Nine patients had serial ECG data
available; all 9 of these patients had the tachycardia since
birth. In this group the mean PJRT cycle length increased
with age, resulting in a slower tachycardia rate (Fig. 2) at
older ages. The mean tachycardia cycle length increased
significantly (p , 0.0001) as the patients developed, result-
ing in a mean tachycardia cycle length of 308 6 64 ms in the
patients less than 2 years of age, 414 6 57 ms in the patients
Figure 2. The PJRT cycle length, measured from serial electro-
cardiograms, is plotted against age in 9 patients presenting during
the first 2 years of life. Two serial electrocardiograms were available
in 3 patients, three in 1 patient, six in 1 patient, seven in 1 patient,
nine in 1 patient, twenty-one in 1 patient and twenty-seven in 1
patient. The data under 2 years of age were obtained from 4 of the
9 patients. To examine for a trend in the data, the curvilinear line
in this figure and in Figures 3 and 4 was created by subjecting the
data to a nonparametric smoothing technique (Systat, Inc, Aurora,
Colorado). Note the gradual increase in cycle length with increas-
ing age. The patients were on no medications for the initial
electrocardiogram; later in their course, digoxin, flecainide and
propranolol were used predominantly, with no effect on the
tachycardia. No measurements were made in the 2 patients during
amiodarone therapy. Although drug effect cannot be fully excluded
from the serial observations depicted in this figure as well as in
Figures 3 and 4, it is unlikely that marked effects occurred given
the persistence of the arrhythmia and the uneven use of and
inconsistent compliance with the antiarrhythmic agents.
Figure 3. The R-P interval, measured from serial electrocardio-
grams, is plotted against age in 9 patients presenting during the
first 2 years of life. The R-P interval is plotted serially for each
subject. The curve describes the trend in the R-P interval at points
during childhood and adolescence. Note the increase in R-P
interval with increasing age in patients with PJRT, and the
similarity of this increase with that of the PJRT cycle length,
suggesting that the slowing of conduction retrograde in the
accessory pathway accounts, for the most part, for the prolongation
of the PJRT cycle length.
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between 2 years and 5 years, and 445 6 57 ms in the
patients greater than 5 years of age. This tachycardia
slowing resulted from significant (p , 0.0001) increases in
both the P-R interval and the R-P interval between the
youngest group and both of the older age groups (Fig. 3 and
4). Importantly, the lengthening of the R-P interval from
mean 204 6 45 ms at age less than 2 years to mean 289 6
52 ms at age greater than 5 years accounted for 64% of the
increase in the tachycardia cycle length. In contrast, the
lengthening of the P-R interval during this time frame from
mean 109 6 25 ms to 156 6 26 ms accounted for only 36%
of the increase in the tachycardia cycle length. Despite these
slower heart rates the tachycardia continued to be unrespon-
sive to multiple medications.
Electrophysiologic findings. Electrophysiologic study in
21 patients (mean age 17.1 years, median age 12.8 years)
demonstrated a tachycardia cycle length at the time of
radiofrequency ablation of 330 ms to 510 ms, with a mean
of 413 ms. Seventeen of the 21 patients had programmed
ventricular extrastimulation during PJRT when the His
bundle was refractory. Data were available from seven; the
mean advancement of the atrial electrogram during ventric-
ular extrastimulation and PJRT was 25 ms 6 12 ms. One of
these seven had neither advancement or delay; however, the
pathway in this patient was located on the left side and
mapped to the middle of the coronary sinus. It was ablated
from the left ventricle. Accessory pathway potentials were
not detected in any patient and were not used as a guide for
the ablation site. Electrophysiologic properties of the atrio-
ventricular node during sinus rhythm and during the tachy-
cardia, including multiple studies in 3 (Table 3), were
normal in the 8 of the 9 patients in whom data were
available (the 1 exception was patient #14 who at 16 years
had recently [stopped 2 weeks before the second electro-
physiology study] been taking amiodarone); no evidence for
enhanced anterograde atrioventricular node conduction or
anterograde or retrograde dual atrioventricular nodal path-
ways was found. Mean conduction retrograde across the
accessory pathway, as measured by the ventriculoatrial
(V-A) block cycle length was slightly, but not statistically
significantly (p 5 0.48), longer than that of anterograde
conduction across the atrioventricular node (block occurring
Table 1. Clinical and Electrocardiographic Data
Patient
# Onset Sex Age @ RFA
Location of
AP
PJRT CL
(ms) at RFA
R-P
(ms) at RFA
P-R
(ms) at RFA
1 Birth M 3.72 Posterior left 350 230 120
2 Birth F 3.83 Right Posterior
Septal
400 260 140
3 NA M 4.45 Superior to CS
Os
440 280 160
4 Birth M 4.66 Right Posterior
Septal
330 220 110
5 6 months F 5.21 CS Os 325 220 105
6 NA F 7.84 CS Os 460 280 180
7 Birth F 8.27 CS Os 400 280 120
8 NA F 9.05 CS Os 400 260 100
9 NA M 10.66 Mid Septal 400 300 100
10B Birth M 10.82 CS Os 510 340 170
11 Birth M 12.82 Right Posterior
Septal
490 340 150
12 Birth F 12.93 CS Os 520 385 135
13 Birth M 15.82 CS Os 430 270 160
14 6 years M 16.15 CS Os 560 400 160
15 NA F 16.79 Right Posterior
Septal
420 300 120
16 Birth M 17.21 Right Posterior
Septal
470 290 180
17 NA F 18.99 Right Posterior
Septal
430 310 120
18 Birth F 20.83 CS Os 460 300 160
19 NA F 34.36 Right Posterior
Septal
360 240 120
20 NA F 41.69 Right Posterior
Septal
550 240 120
21 NA M 83.59 CS Os 410 250 160
AP 5 Accessory pathway; CL 5 Cycle length; CS Os 5 Coronary sinus os; NA 5 Not available; P-R 5 PR interval on the electrocardiogram (see Methods); R-P 5 RP interval
on the electrocardiogram (see Methods); RFA 5 Radiofrequency ablation.
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at a mean 374 ms anterograde versus 407 ms retrograde).
The retrograde effective refractory period (ERP) of the
accessory pathway available in 8 patients ranged from
220 ms to 420 (excluding the patient #14 recently on
amiodarone), mean 302 ms. The functional refractory pe-
riod (FRP) of the accessory pathway, available in 8 patients
(excluding the data from patient #14), was mean 400 ms,
similar to the mean tachycardia cycle length mean (440 ms).
The anterograde ERP of the atrioventricular node was
shorter than that of the retrograde accessory pathway in 8 of
11 patients in whom it was recorded. The anterograde FRP
of the atrioventricular node was shorter than that of the
retrograde accessory pathway in 8 of 9 patients in whom it
was recorded. Three patients (excluding #14) had more than
one electrophysiology study. Anterograde properties of the
atrioventricular node changed only slightly; in patient #2,
the ERP remained the same but the FRP lengthened,
perhaps related to the longer drive interval. Patient #12’s
FRP was the same, but the measured ERP was shorter in
the 9 year interval, due to more vigorous study techniques
such as stimulation at multiple sites. Patient #18 received
isoproterenol at the third study confounding comparison
over time. Serial retrograde data were available only on
patient #18; there was little change except that most likely
due to increased age and isoproterenol. The 3 patients
(mean age 14 years) whose clinical course exhibited a
paroxysmal pattern were compared to the 18 subjects (mean
age 18 years) whose tachycardia was constant. Both the
mean PJRT cycle length (423 6 68 ms) and the retrograde
conduction interval (279 6 50 ms) of the 18 patients (mean
age 17 years) (Table 1) with the constant form was signif-
icantly (p , 0.036) shorter than those (487 6 25 ms; 327 6
23 ms) of the 3 patients with the paroxysmal form (mean
age 14 years).
The retrograde slowly conducting accessory pathway
bridges the atrioventricular groove inserting near the groove
in the ventricle (13) and was located at the coronary sinus
ostium in 10 patients: in the right posterior septum region
Figure 4. The P-R interval, measured from serial electrocardio-
grams, is plotted against age in 9 patients presenting during the
first 2 years of life. The P-R interval is plotted serially for each
subject. The curve describes the trend in the P-R interval at points
during childhood and adolescence. In contrast to the R-P interval
in these patients, there is only the expected age related increase in
the P-R interval over the first 15 years of life.
Table 2. Summary of Medications Tried for Control of PJRT
# Digoxin Flecainide
Beta
Blockers Quinidine Other
1 1 0 1 0
2 1 1 0 0
3 1 1 1 0
4 1 1 0 0
5 1 1 1 1
6 1 1 0 0
7 1 0 1 1
8 1 1 1 0 Amiodarone
9 1 0 0 0
10 0 0 0 0
11 1 0 1 0
12 1 0 1 0
13 1 0 1 1
14 1 0 1 0 Amiodarone
15 0 0 0 0
16 0 0 0 0
17 1 0 1 0 Propafenone
18 1 0 1 0
19 1 0 1 0 Propafenone &
CaChBl
20 0 0 1 0 CaChBl
21 1 0 1 1
0 5 Not used; 1 5 used; CaChBl 5 Calcium Channel Blocker.
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in 8 patients, just superior to the coronary sinus in 1 patient,
in the midseptum area in 1 patient and in the left posterior
septal region in 1 patient.
Ventricular function. Fifteen of the 21 patients were
evaluated by echocardiography at presentation; 11 demon-
strated a mean shortening fraction of 0.22 6 0.05 (range 5
0.15 to 0.30; normal $0.28) and E-point septal separation,
consistent with decreased ventricular function. Four of 11
patients with decreased myocardial function had clinical
symptoms of severe congestive heart failure as infants. The
remaining 7 patients increased their mean shortening frac-
tion from 0.20 to 0.32 after successful ablation of the
accessory pathway. Interestingly, shortening fraction in-
creased spontaneously in 3 of the 11 patients (from a mean
0.23 to a mean of 0.36) with increasing age and slower heart
rates (2 patients’ PJRT heart rate decreased from 183 to 119
and 128 to 104 respectively, and one patient’s rhythm
converted to sinus rhythm on amiodarone therapy). Echo-
cardiographic data could not be interpreted in one patient
because of an implanted pacemaker. The clinical impression
and follow-up of the infants suggested that tachycardia-
related decreased ventricular function was prominent in this
group (who had faster PJRT heart rates) and that an
improvement in ventricular function was associated with
decreasing heart rates; however, due to the limited number
of infants studied, this association was not statistically
significant.
Drug therapy. Pharmacological management in these pa-
tients was unsuccessful in all but patient #14; he had
received ineffectual trials of several medications but was
eventually successfully treated with amiodarone; however,
hyperthyroidism and noncompliance complicated this ap-
proach and ablation was recommended and successfully
performed.
Radiofrequency ablation. The median age at ablation was
12.8 years. One patient underwent successful surgical cryo-
ablation of the accessory pathway at age 15 years prior to the
advent of radiofrequency ablation. The remaining 20 un-
derwent radiofrequency ablation. The shortest ventricu-
loatrial conduction time was used to identify the site of
energy application. Seventeen of 21 accessory pathways
(81%) were located at the coronary sinus ostium or in the
right posterior septal region; the pathways of the remaining
4 patients were in the free wall (Table 1). Two to 35
radiofrequency energy applications were performed in the
19 patients; ablation of the pathway was successful in 16 of
the 21 patients during the initial session. One patient was
thought to have multiple pathways and the accessory path-
way supporting PJRT was not successfully ablated. This
patient declined a second trial of radiofrequency energy
application. Transient ablation occurred in 5 patients; re-
currence of the tachycardia was noted at less than one hour,
and at 1, 3 and 7 days after ablation. Radiofrequency
ablation for recurrence was successful in all but one. Patient
#5, a 5-year-old boy with diminished ventricular function,
developed complete heart block at his third session. The
location of the pathway in this patient was posterior, near
the coronary sinus os. During radiofrequency application,
the catheter tip abruptly recoiled from its mapped site near
the coronary sinus os to the apex of triangle of Koch; an
immediate 3 second run of rapid junctional tachycardia
ensued. The energy was discontinued at the end of the 3
seconds, but complete permanent heart block was present.
The escape rhythm was a His bundle rhythm at 55 beats per
Table 3. Electrophysiologic Data—Anterograde
Pt #
Age/EPS
(yr) SCL A-H H-V PCL AVNERP AVNFRP WB CL*
1 3.67 870 120 50 600 360 420 500
2 0.5 275(PJRT) 78 20 NA NA NA NA
2 0.5 375 75 35 275(PJRT) #190 245 NA
2 3.83 600(AP) 80 35 500 #150 340 NA
4 4.66 333(AP) 70 35 333(AP) #190 330 310
10 10.82 600 50 35 500(AP) #190 330 310
12 3.83 383(PJRT) 110 45 385(PJRT) 315 330 #286
12 12.93 505 95 40 450 #180 320 260
13 15.5 430(PJRT) 84 37 450(PJRT) #170 360 #333
14 5.8 370(PJRT) 93 46 360(AP) 230 340 300
14 16.15 1020 10 40 550(PJRT) 480 540 520
16 17.51 460(PJRT) 150 45 450(AP) 320 370 370
18 7.42 670 100 40 600(AP) 340 370 #333
18 13 1040 140 37 470(PJRT) 370 420 420
18 19.83 1185 85 40 NA NA NA 600
18 20.83 705 90 45 400(PJRT: Isop) 270 335 .700
A-H 5 A-H interval; AP 5 Programmed extrastimulation coupled to atrial pacing; AVNERP 5 Atrioventricular node effective refractory period; AVNFRP 5 Atrioventricular
node functional refractory period; EPS 5 Electrophysiology study; H-V 5 H-V interval; Isop 5 During isoproterenol infusion; * 5 No isoproterenol infusion; PCL 5 Pacing
cycle length; PJRT 5 Programmed extrastimulation coupled to the persistent junctional reciprocating tachycardia; NA 5 Not available; SCL 5 Sinus cycle length; WB CL 5
Pacing cycle length that conduction block occurred (Wenckebach).
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minute with a narrow (normal) QRS complex; a pacemaker
was implanted. During the procedure another patient with
a left-sided pathway demonstrated persistent tachycardia
after transient successful (15 min) radiofrequency ablation,
but at follow-up electrophysiologic study 6 months later, he
was in normal sinus rhythm, had no inducible tachycardia
and no electrophysiologic evidence for a persistent pathway
(20). Following radiofrequency ablation, retrograde conduc-
tion was absent in two patients of the seven patients studied
(Table 4). In addition, the ventricular pacing rate at which
retrograde block occurred, presumably through the His-
Purkinje atrioventricular node, as indicated by the shortest
V-A interval recorded in the His bundle region, was slower
in the four other patients studied after ablation than that
observed prior to ablation. Follow-up after definitive treat-
ment (i.e., following all RFA sessions) ranges from 2.9 to 8
years without reoccurrence, except in the patient who has
declined a second ablation attempt. The one patient with
the pacemaker is doing well.
DISCUSSION
These data demonstrate a wide clinical spectrum and new
features of PJRT. Most authors use the term permanent
rather than persistent junctional reciprocating tachycardia
(1–10,14); however, because of the wide age range at
presentation, the lack of permanency in a number of
patients and the advent of corrective therapy, we suggest the
use of persistent, conveying more frequency than intermit-
tent but less than permanent. Eighty percent of the patients
in our study presented during childhood (#18 years) and
50% presented during the first year of life. However,
clinically asymptomatic patients presenting later are not
uncommon, due to perhaps, as suggested by the clinical
course of several of our patients, unrecognized paroxysmal
relatively “slow” tachycardia for many years.
PJRT makes its appearance most often in early childhood.
To examine for a trend in the data with age, the curvilinear
lines in Figures 2, 3 and 4 were created by subjecting the data
to a nonparametric smoothing technique (Systat, Inc, Aurora,
Colorado). The patients were on no medications for the initial
electrocardiogram; within the first 2 years as well as later in
their course digoxin, flecainide and propranolol were used
predominantly, with no effect on the tachycardia. No measure-
ments were made in the two patients during amiodarone
therapy. Although drug effect cannot be fully excluded from
the serial observations depicted in these figures, it is unlikely
that marked effects occurred given the persistence of the
arrhythmia and the uneven use of and inconsistent compliance
with the antiarrhythmic agents. Thus, during the first several
years of life, the rate tends to slow as a function of delay in
conduction not only in the normal atrioventricular His-
Purkinje axis but also, and most importantly, in the concealed
accessory pathway. At about two years of age, the PJRT rate
and conduction in both directions tend to stabilize (Fig. 3 and
Table 4. Electrophysiologic Data—Retrograde
Patient
#
Age at
EPS
(yr)
PJRT
CL(ms)
PCL(ms)
(Drive)
APERP
(ms)
Retrograde
APFRP
(ms)
Retrograde
CL(MS)
RETRO
WB
Post
RFA—
No
Eccentric
VA
Conduction
Post
RFA—
No
Inducible
Tachycardia
Post RFA Retro
WB (CL)
1 3.67 490 400(VP) 260 340 NA 1 1 520
2 0.5 270 270(VP) 240 270 260 2
2 3.83 400 NA NA NA NA 1 1 240
4 4.66 330 330(PJRT) 220 NA NA 1 1 NA
10 10.82 450 500(VP) 220 380 370 1 1 #480
12 3.83 385 385(PJRT) 330 380 NA 2
12 12.93 520 350(VP) 280 340 400 1 1 570
13 15.5 430 400(VP) 330 440 350 1 NA
14 5.8 365 365(PJRT) 280 335 NA 2
14 16.15 600 700(VP) 570 610 630 1 No VA
conduction
16 17.21 470 470(PJRT) 400 450 450 1 1 530
18 7.42 430 430(VP) 420 425 420 2
18 13 470 NA NA NA 420 2
18 19.83 400(Isop) 600(VP) #260 450 420 2
18 20.83 435(Isop) 600(VP) 340 400 350 1 No VA
conduction
AP 5 Programmed extrastimulation coupled to atrial pacing; APERP 5 Accessory pathway effective refractory period; APFRP 5 Accessory pathway functional refractory period;
EPS 5 Electrophysiology study; RFA 5 Radiofrequency ablation; Isop 5 During isoproterenol infusion; p 5 No isoproterenol infusion; PCL 5 Pacing cycle length; PJRT 5
Programmed extrastimulation coupled to the persistent junctional reciprocating tachycardia; NA 5 Not available (Blank cells denote no post ablation study); SCL 5 Sinus cycle
length; VA 5 Ventriculoatrial; VP 5 Programmed extrastimulation coupled to ventricular pacing; WB CL 5 Pacing cycle length that conduction block occurred (Wenckebach);
1 5 Positive.
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4). Some patients, as illustrated by three patients in this cohort
in whom “persistence” of the tachycardia was dependent upon
isoproterenol, and, perhaps, by our older patients as well, may
revert to a more paroxysmal form (14).
In contrast to our experience, Yagi et al. have reported
that, despite the concordance in the mean PJRT cycle
length between their paroxysmal and incessant groups,
retrograde conduction through the accessory pathway was
significantly shorter in the paroxysmal form compared to the
incessant form (14). Conversely, anterograde conduction via
the atrioventricular node was significantly shorter in the
incessant form than in the paroxysmal form of tachycardia.
Our patients differed from their group. Their patient group
was, on the average, considerably older than our patient
group. In addition, our younger patients (,10 years) had a
significantly shorter mean PJRT cycle length and faster
tachycardia then either of their 2 groups. Our three patients
with the paroxysmal form, in contrast to the patients of Yagi
et al., were converted to the incessant form with isoproter-
enol. Among our cohort the incessant tachycardia was
associated not only with shorter PJRT cycle lengths and
retrograde conduction intervals but also with slightly
younger ages. Thus, our experience, in conjunction with the
study of Yagi et al. and others (14,15), suggests that patients
with PJRT comprise a wide clinical spectrum.
These data suggest that the cycle length of PJRT in-
creases with age (Fig. 2, 3 and 4). Average tachycardia rates
are much faster in infants and younger patients than in older
patients. Although slowing of conduction both anterograde
through the normal atrioventricular node–His-Purkinje axis
and retrograde through the accessory pathway contributes to
the increase in the tachycardia cycle length and occurs at
similar rates (similar shaped curves in Fig. 3 and 4), this
age-related change in the tachycardia rate is primarily
dependent upon prolongation of retrograde conduction
through the accessory pathway. Furthermore, as indicated
by the data from these patients, the conduction properties of
the retrograde accessory pathway are slower compared to
those of the anterograde atrioventricular node and com-
pared to those of the usual “fast” accessory pathway found in
patients with atrioventricular reentrant tachycardia. How-
ever, a recent study indicating that the ventricular insertion
of the accessory pathway inserts at the atrioventricular
groove and not deep within the right ventricular rejects the
notion that an increased length of the accessory pathway
accounts for the “slow” retrograde conduction (13). On the
other hand, because the conduction properties as well as the
anatomic location of the retrograde accessory pathway in
these patients are similar (but clearly anatomically indepen-
dent) to those of the atrioventricular node anterograde, one
may postulate that factors that are influential in atrioven-
tricular conduction, such as abundant autonomic innerva-
tion, membrane-channel function, adenosine and beta1
receptor densities and decremental conduction may also be
similar between the two pathways. In addition, because the
PJRT cycle length, as expected, tracks much more with the
functional refractory period of the retrograde accessory
pathway as the patient ages (Tables 1, 3 and 4) than with
properties of the anterograde atrioventricular node, it is
apparent that changes in the retrograde pathway are the
major factors in the difference in clinical courses observed in
different patients.
Patients with PJRT may present with clinical or labora-
tory findings of impaired ventricular function compatible
with tachycardia related cardiomyopathy. The tachycardia
has infrequent spontaneous, but intermittent periods of
remission. In older patients the tachycardia appears to be
less incessant, perhaps due to variable autonomic tone.
Because the PJRT heart rates are faster at younger age and
since congestive heart failure is more common at younger
ages, the two may be related. Even though a general trend
seemed to support this hypothesis, a statistical significance,
due to limited sample size, could not be demonstrated. This
observation may also be, in part, due to limitations to
accurately assess ventricular function by available noninva-
sive means. Three patients with cardiomyopathy in this
study improved spontaneously, perhaps associated with the
progressively slower rate of the tachycardia as the patient
grew older; however, one of these three patients improved
with only a slight decrease in the tachycardia rate. Because
reversibility of tachycardia induced cardiomyopathy is well
known (16–19), intractable tachycardia-related decreased
function in the older patient may be best managed with
radiofrequency ablation of the retrograde accessory pathway.
Furthermore, there are no ideal or even satisfactory antiar-
rhythmic medications for this arrhythmia. Because of uni-
form, full recovery of ventricular function occurring either
postablation or spontaneously, intervention with either ami-
odarone or radiofrequency ablation should be considered
only when cardiac function is severely impaired for a
minimum of 1–2 yr or when the patient is of adequate size
for a safe ablation attempt.
Several investigators have demonstrated that radiofre-
quency ablation can be used effectively for the treatment
of PJRT (7,8,10,15). Our study confirms that radiofre-
quency ablation can be extended effectively for the
treatment of PJRT to most patients. Five patients (24%)
experienced recurrence and required repeat sessions for
successful ablation; these patients received ablation dur-
ing the first four years of our radiofrequency programs,
perhaps accounting, in part, for the recurrence rate.
Although one of our patients experienced complete heart
block as a result of an abrupt spontaneous shift in the
position of the catheter tip, this complication (20), given
the usual anatomy of the pathway distant from the
atrioventricular node and His bundle, should be a very
rare event. Furthermore, the observation of spontaneous
resolution of ventricular dysfunction and the increased
complications at smaller than 15 kg along with the
experimental evidence that links an expansion of radio-
frequency lesion size (in the canine ventricle, but, inter-
estingly, not the porcine ventricle) with subject growth
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and age (21–23) suggest deferment of ablation in small
children until they are of sufficient size or until significant
symptoms develop. However, radiofrequency should be
considered as treatment for patients with intractable
tachycardia, and especially for those with decreased
ventricular function, or with symptoms attributable to the
persistent tachycardia. Patients with recurrent or persis-
tent tachycardia after the initial attempt of radiofre-
quency can be considered for repeat radiofrequency
ablation of their accessory pathway.
Clinical implications. PJRT is an arrhythmia that usu-
ally presents in infancy or childhood, but may not be
recognized until adulthood. Symptoms of congestive
heart failure are more common in younger patients. Some
patients may be unaware of the underlying persistent
tachycardia and may present with decreased ventricular
function, exercise intolerance or syncope much later in
life. Age-related changes in both the rate and the
“persistence” of this tachycardia may mask its diagnosis.
The heart rate relative to different ages may not be
sufficiently fast to result in symptoms or to provoke
further examination by the patient’s physician; thus, the
diagnosis may be delayed until tachycardia related symp-
toms or paroxysms of palpitations and tachycardia be-
come apparent to the patient or patient’s family. Since
the heart rate associated with PJRT will most likely slow
with age, radiofrequency ablation may be deferred in
small children with this tachycardia. However, because
the tachycardia has both an infrequent spontaneous (and
intermittent) resolution (1/21 in our series) and a variable
expression of impaired ventricular function, and since it
may be effectively and safely treated with radiofrequency
ablation, we recommend that electrophysiologic study
and radiofrequency ablation should be considered at
suitable patient size ($15 kg) and upon the appearance of
symptoms related to the tachycardia and/or impaired
ventricular function.
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